Simple Summary Inflammation has been recognized to be linked to tumor development.
Several markers of inflammation can be detected via blood such as variety of blood cells …

Urothelial carcinoma (UC) can occur in various parts of the urinary tract and occurs in
different stages and grades. The disease recurs frequently and is monitored through a series …

Aim: To investigate the prognostic role of neutrophil percentage-to-albumin ratio (NPAR) in
muscle-invasive bladder cancer (MIBC) patients treated with neoadjuvant chemotherapy …

Background Predicting the response to treatment with nivolumab and the survival in patients
with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) remains a …

Introduction The neutrophil-to-lymphocyte ratio (NLR) is an attractive marker because it is
derived from routine bloodwork. NLR has shown promise as a prognostic factor in muscle …

ABSTRACT Intravesical Bacille Calmette-Guérin (BCG) remains the most effective treatment
for high-risk non-muscle-invasive bladder cancer (NMIBC), unfortunately there is no …

Neoadjuvant cisplatin-based chemotherapy (NACC) followed by radical cystectomy is the
standard treatment for localized muscle-invasive bladder cancer (MIBC). Patients who …

There is a rising need for optimal biomarkers to better tailor treatments for patients with
cancer in the era of immunotherapy. In addition to programmed death-ligand 1 (PD-L1) and …

Introduction and objective Lung immune prognostic index score (LIPI), calculated using the
derived neutrophil–lymphocyte ratio and lactate dehydrogenase level, is reported for use in …

Biomarker approach is a necessary step to usher the age of precision/personalized
medicine for muscle-invasive UCB with the overarching good to prevent both over-and …